Institutional investors purchased a net $5.5 million shares of LLY during the quarter ended June 2015 and now own 66.36% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JPMORGAN INVESTMENT MANAGEMENT, ... Bought 7.1 Million shares of Eli Lilly and Co
CAPITAL RESEARCH & MANAGEMENT CO... Bought 5.9 Million shares of Eli Lilly and Co
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.7 Million shares of Eli Lilly and Co